Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Oncol., 03 December 2025

Sec. Neuro-Oncology and Neurosurgical Oncology

Volume 15 - 2025 | https://doi.org/10.3389/fonc.2025.1748919

Correction: Case Report: FGFR1 mutation and massive chromosome loss drive malignant transformation of low-grade gliomas

  • 1Department of General Surgery, Children’s Hospital of Soochow University, Suzhou, China
  • 2Department of Neurosurgery, The Second Affiliated Hospital of Soochow University, Suzhou, China
  • 3Advanced Molecular Pathology Institute of Soochow University and SANO, Suzhou, China
  • 4Suzhou SANO Precision Medicine Ltd, SANO Medical Laboratories, Suzhou, China
  • 5Department of Neurosurgery, Children’s Hospital of Soochow University, Suzhou, China
  • 6Department of Pathology, The Second Affiliated Hospital of Soochow University, Suzhou, China
  • 7Department of Biological Sciences, Xi An Jiaotong-Liverpool University, Suzhou, China

A Correction on
Case Report: FGFR1 mutation and massive chromosome loss drive malignant transformation of low-grade gliomas

by Tang R, Chen Y, Wan D, Xiang Y, Chen S, Chen H, Dai X, Rong R, Xiao S, Lan Q, Wang H and Huang S (2025). Front. Oncol. 15:1694881. doi: 10.3389/fonc.2025.1694881

Affiliation “Department of Neurosurgery, The Second Affiliated Hospital of Soochow University, Suzhou, China” was omitted for author “Qing Lan”. This affiliation has now been added for author “Qing Lan”.

Author “Qing Lan” was erroneously assigned to affiliation “Department of General Surgery, Children’s Hospital of Soochow University, Suzhou, China”. This affiliation has now been removed for author “Qing Lan”.

The Conflict of interest statement has been correct to “Authors DW, SC, HC, and SX were employed by Suzhou SANO Precision Medicine Ltd.

The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest”.

The original version of this article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: FGFR1, haploidy, glioma, malignant transformation, methylation

Citation: Tang R, Chen Y, Wan D, Xiang Y, Chen S, Chen H, Dai X, Rong R, Xiao S, Lan Q, Wang H and Huang S (2025) Correction: Case Report: FGFR1 mutation and massive chromosome loss drive malignant transformation of low-grade gliomas. Front. Oncol. 15:1748919. doi: 10.3389/fonc.2025.1748919

Received: 18 November 2025; Accepted: 19 November 2025; Revised: 19 November 2025;
Published: 03 December 2025.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2025 Tang, Chen, Wan, Xiang, Chen, Chen, Dai, Rong, Xiao, Lan, Wang and Huang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Qing Lan, c3pscTAwNkAxNjMuY29t; Hangzhou Wang, d2FuZ2hhbmd6aG91ZHJAMTI2LmNvbQ==; Shungen Huang, ZHJodWFuZzAxQDE2My5jb20=

These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.